Interpretation to the 2023 clinical consensus statement for definition, epidemiology, management and prevention by the Heart Failure Association of the European Society of Cardiology

ZHANG Yanan, Siriguleng, YANG Hongxin, GUO Xiaobin

PDF(1326 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(1326 KB)
World Clinical Drug ›› 2023, Vol. 44 ›› Issue (10) : 1017-1021. DOI: 10.13683/j.wph.2023.10.001
Topic

Interpretation to the 2023 clinical consensus statement for definition, epidemiology, management and prevention by the Heart Failure Association of the European Society of Cardiology

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 44(10): 1017-1021 https://doi.org/10.13683/j.wph.2023.10.001

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1326 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉